# OnCo record paper-ata-anaplastic-thyroid-guideline-bible-thyroid-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ata-anaplastic-thyroid-guideline-bible-thyroid-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ata-anaplastic-thyroid-guideline-bible-thyroid-2021" ;
  schema:name "2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer"@en ;
  schema:description "The updated American guideline for anaplastic thyroid cancer stresses molecular testing within days of diagnosis, BRAF-MEK inhibitors for BRAF-mutant disease including before surgery, multimodal therapy for resectable disease, and early goals-of-care discussions."@en ;
  schema:url <https://onco.cc/key-papers/paper-ata-anaplastic-thyroid-guideline-bible-thyroid-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1089/thy.2020.0944>, <https://pubmed.ncbi.nlm.nih.gov/33728999/> ;
  schema:sameAs <https://doi.org/10.1089/thy.2020.0944> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Bible KC, Kebebew E, Brierley J, et al." ;
  onco:cancers <https://onco.cc/cancers/anaplastic-thyroid-cancer/> .